Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Test Type
2.3.2 Market Size By Age Group
2.3.3 Market Size By Sector Type
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Pricing Analysis & Forecast By Test Type, 2022–2035
4.1.3 Price Benchmarking By Key Players, 2024
4.2 Regulatory Landscape
4.2.1 Overview
4.2.2 Regulatory Trends By Key Countries
4.2.3 Regulatory Outlook By Screening Programs
4.2.4 Regulatory Outlook By Diagnostic Technology Type
4.3 Trade Analysis
4.3.1 Overview
4.3.2 Import Analysis (Value & Volume), By Country, 2021–2025
4.3.3 Export Analysis (Value & Volume), By Country, 2021–2025
4.3.4 Major Importing Regions & Healthcare Systems
4.3.5 Major Exporting Regions & Diagnostic Manufacturing Hubs
5. Sickle Cell Anemia Testing and Screening Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Hemoglobin Electrophoresis
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 High-Performance Liquid Chromatography
5.4 Point-of-Care Tests
5.5 Others
6. Sickle Cell Anemia Testing and Screening Market Segmental Analysis & Forecast, By Age Group, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Newborn Screening
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Adult Screening
6.4 Other Age Groups
7. Sickle Cell Anemia Testing and Screening Market Segmental Analysis & Forecast, By Sector Type, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Government Labs
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Private Labs
7.4 Corporate Labs
7.5 Public-Private Partnerships
8. Sickle Cell Anemia Testing and Screening Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Test Type, 2022–2035
8.2.3 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Age Group, 2022–2035
8.2.4 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Sector Type, 2022–2035
8.2.5 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Country, 2022–2035
8.2.5.1 USA
8.2.5.2 Canada
8.3 Europe
8.3.1 Key Trends
8.3.2 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Test Type, 2022–2035
8.3.3 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Age Group, 2022–2035
8.3.4 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Sector Type, 2022–2035
8.3.5 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Country, 2022–2035
8.3.5.1 Germany
8.3.5.2 UK
8.3.5.3 France
8.3.5.4 Italy
8.3.5.5 Spain
8.3.5.6 Russia
8.3.5.7 Poland
8.3.5.8 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Test Type, 2022–2035
8.4.3 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Age Group, 2022–2035
8.4.4 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Sector Type, 2022–2035
8.4.5 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Country, 2022–2035
8.4.5.1 China
8.4.5.2 India
8.4.5.3 Japan
8.4.5.4 South Korea
8.4.5.5 Australia
8.4.5.6 ASEAN Countries
8.4.5.7 Rest of Asia-Pacific
8.5 Latin America
8.5.1 Key Trends
8.5.2 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Test Type, 2022–2035
8.5.3 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Age Group, 2022–2035
8.5.4 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Sector Type, 2022–2035
8.5.5 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Country, 2022–2035
8.5.5.1 Brazil
8.5.5.2 Argentina
8.5.5.3 Mexico
8.5.5.4 Colombia
8.5.5.5 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Test Type, 2022–2035
8.6.3 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Age Group, 2022–2035
8.6.4 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Sector Type, 2022–2035
8.6.5 Sickle Cell Anemia Testing and Screening Market Size & Forecast, By Country, 2022–2035
8.6.5.1 UAE
8.6.5.2 Saudi Arabia
8.6.5.3 Qatar
8.6.5.4 South Africa
8.6.5.5 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2025
9.2.2 Year-Wise Strategies & Development, 2022–2025
9.2.3 Number Of Strategies Adopted By Key Players, 2025
9.3 Market Share Analysis, 2025
9.4 Test Type/Service & Age Group Benchmarking
9.4.1 Test Type/Service Specifications & Features By Key Players
9.4.2 Test Type/Service Heatmap By Key Players
9.4.3 Age Group Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Bio-Rad Laboratories Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Test Type/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 Thermo Fisher Scientific Inc.
9.6.3 Abbott Laboratories
9.6.4 PerkinElmer Inc.
9.6.5 Danaher Corporation
9.6.6 Siemens Healthineers AG
9.6.7 Roche Diagnostics
9.6.8 Cepheid Inc.
9.6.9 Natera Inc.
9.6.10 Trinity Biotech plc
9.6.11 BioMedomics Inc.
9.6.12 Hemex Health Inc.
9.6.13 Quest Diagnostics Incorporated
9.6.14 Laboratory Corporation of America Holdings
9.6.15 STRECK Inc.
9.6.16 Silver Lake Research Corporation
9.6.17 Agilent Technologies Inc.
9.6.18 bioMérieux SA
9.6.19 Beckman Coulter Inc.
9.6.20 Sysmex Corporation
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
Frequently Asked Questions
Ans: North America dominated with 43.60% of global revenues in 2025, led by the United States with all-50-states newborn screening mandates, approximately 100,000 affected Americans requiring ongoing diagnostic monitoring, significant NIH research investment, and the most advanced gene therapy clinical infrastructure creating diagnostic demand for patient evaluation and post-treatment monitoring.
Ans: Point-of-Care Tests are the fastest-growing test type, driven by critical public health necessity of making accurate sickle cell diagnosis accessible in community clinic environments of sub-Saharan Africa and rural India where laboratory-based testing infrastructure is unavailable.
Ans: Hemoglobin Electrophoresis dominated the market in 2025 as the established diagnostic method for sickle cell disease confirmation and haemoglobin variant identification.
Ans: Progressive expansion of government-mandated newborn sickle cell screening programmes globally creating institutional testing demand, combined with the gene therapy era requirement for comprehensive pre-treatment patient evaluation and post-treatment monitoring diagnostic testing.
Ans: The Sickle Cell Anemia Testing and Screening Market was valued at USD 494.8 million in 2025.
Ans: The Sickle Cell Anemia Testing and Screening Market is expected to grow at a CAGR of 12.30% from 2026 to 2035.
Get in Touch
